A large number of antioxidant based strategies focusing on ascorbic acid, deferoxamine, cucurmin etc has been investigated for management of the PD symptoms but without any translatable benefits 47,48
G., Sullivan, A., Rael, L
The TRANSCEND-T2D-1 trial demonstrated A1C reductions of up to 2.0% and weight loss of up to 16.8% at 40 weeks, with no plateau observed through the end of the treatment period
The inclusion of BPC-157 signals that a major international body has determined it poses a potential risk
McManus, and S
Here, we show that hepsin deficiency in mice exacerbates acetaminophen toxicity compared to wild-type mice, leading to more severe liver pathology, elevated oxidative stress, and greater mortality within 6 h after exposure